Search for " " - 2/469

Results for “ ”

Entry	Author	Date	Location
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting	Ben Fidler	05/07/19	National
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks	Alex Lash	05/07/19	Boston
LunaDNA, Vivid & More: The Xconomy Awards San Diego Startup Finalists	Alex Lash	05/06/19	San Diego
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea	Ben Fidler	05/06/19	New York
Lundbeck to Buy Abide Therapeutics For $250M, Make SD Lab a US Hub	Sarah de Crescenzo	05/06/19	San Diego
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More	Alex Lash	05/03/19	National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments	Frank Vinluan	05/03/19	National
New VC Firm Blueprint Equity Puts $6M into Florida Software Company	Sarah de Crescenzo	05/02/19	San Diego
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan	David Holley	05/02/19	Texas
Ivor Royston Named Xconomy’s 2019 Lifetime Achievement Award Winner in San Diego	Sarah de Crescenzo	05/02/19	San Diego
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?	Ben Fidler	05/02/19	National
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists	Jeff Engel	05/01/19	San Diego
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding	David Holley	04/30/19	Texas
Roche Spinout Nimble Therapeutics Bags $10M to Find New Peptide Drugs	Jeff Engel	04/30/19	Wisconsin
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO	Ben Fidler	04/30/19	Boston
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic	Sarah de Crescenzo	04/30/19	San Diego
Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center	Sarah de Crescenzo	04/29/19	San Diego
Peloton Therapeutics Plans IPO for Kidney Cancer Drug Clinical Trials	Angela Shah	04/29/19	Texas
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana	Frank Vinluan	04/26/19	Indiana
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More	Frank Vinluan	04/26/19	National
Roswell, Organovo & More: Xconomy Awards Innovation at the Intersection Finalists	Corie Lok	04/25/19	San Diego
After NASH Drug’s 2nd Failure, Gilead Pins Hopes on Combo Therapies	Frank Vinluan	04/25/19	San Francisco
Avidity Biosciences Gets $35M in Immunology R&D Deal with Eli Lilly	Sarah de Crescenzo	04/24/19	San Diego
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up	Jeff Engel	04/24/19	Wisconsin
Forge Therapeutics, Basilea Sign Deal to Pursue New Antibiotics	Sarah de Crescenzo	04/24/19	San Diego
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience	Ben Fidler	04/24/19	Boston
Teva’s Approved Migraine Drug Fails Again to Blunt Rarer Headache	Frank Vinluan	04/23/19	New York
Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings	Jeff Engel	04/23/19	Wisconsin
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson	Alex Lash	04/23/19	Boston
Xconomy’s Seattle Event to Explore Tech Convergence in Life Sciences	Frank Vinluan	04/22/19	Seattle
Page 2 of 371	« previous page · next page »